Product Information
FELBAMATE 600 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.2557 per EA under NDC 51525043101. Its NADAC has been published 649 times since Nov 28, 2013.
FDA first approved this application on Jul 29, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
51525043101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
FELBAMATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020189FDA Approved
7/29/1993
TE Code
AB
On Market Since
11/11/2011
Pharmacological Classes
Price Statistics
The NADAC for FELBAMATE 600 MG TABLET has been published 649 times since Nov 28, 2013, and over the history we have for it it has declined 70.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2557 per EA |
|---|---|
| All-time high | $4.4305 (Apr 16, 2014) |
| All-time low | $0.7362 (Apr 19, 2023) |
| 52-week high | $1.4595 |
| 52-week low | $1.2134 |
| Median price | $2.6684 |
| Average price | $2.5977 |
| Largest weekly change | +80.5% (Oct 20, 2021) |
| Weeks tracked | 649 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
+3.5%
1Y
-14.0%
3Y
+15.4%
5Y
-46.8%
All
-70.6%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FELBAMATE 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FELBAMATE 600 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $1.2557 per EA (NDC 51525043101), effective Apr 29, 2026.
How has the price of FELBAMATE 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for FELBAMATE 600 MG TABLET has declined 70.6%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FELBAMATE 600 MG TABLET?
Since Nov 28, 2013, the NADAC for FELBAMATE 600 MG TABLET has ranged from a low of $0.7362 (Apr 19, 2023) to a high of $4.4305 (Apr 16, 2014), with a median of $2.6684 per EA.
Are there cheaper alternatives to FELBAMATE 600 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FELBAMATE 600 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FELBAMATE 600 MG TABLET?
FELBAMATE 600 MG TABLET (NDC 51525043101) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.